[시장보고서]줄기세포 어세이 시장 - 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 분석 유형별, 세포 유형별, 용도별, 최종 용도별, 지역별 부문 예측(2025-2033년)

줄기세포 어세이 시장 - 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 분석 유형별, 세포 유형별, 용도별, 최종 용도별, 지역별 부문 예측(2025-2033년)

Stem Cell Assays Market Size, Share & Trends Analysis Report By Product, By Assay Type, By Cell Type, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033

상품코드 : 1869607

리서치사 : Grand View Research

발행일 : 2025년 10월

페이지 정보 : 영문 150 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,828,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,311,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,279,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

줄기세포 어세이 시장 요약

세계의 줄기세포 어세이 시장 규모는 2024년 39억 2,000만 달러로, 2033년까지 128억 5,000만 달러에 이를 것으로 예측됩니다.

2025년부터 2033년까지 연평균 복합 성장률(CAGR) 14.80%로 성장할 것으로 전망됩니다. 신약개발, 질병 모델링 및 재생 의료에서 생리적으로 관련성이 높은 모델 수요 증가는 시장 성장을 견인하는 주요 요인입니다.

제약 회사와 연구자들은 기존 모델(오가노이드 및 iPS 세포 기반 시스템 등)보다 인간 조직에 가깝게 신뢰할 수 있는 플랫폼을 찾고 있습니다. 이러한 분석은 약물의 효능과 안전성 예측 정확도를 향상시켜 후기 단계에서 실패율을 줄이고 새로운 치료법의 개발을 가속화합니다.

지역별 시장 점유율 분석, 2024년 및 2033년
지역별 시장 대시보드
시장 규모, 예측 동향 분석, 2021-2033년:
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 스웨덴
- 덴마크
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제10장 경쟁 구도

기업/경쟁의 분류
전략 매핑
기업시장 포지셔닝 분석, 2024년
기업 프로파일
- Thermo Fisher Scientific Inc.
- Merck KGaA
- STEMCELL Technologies Inc.
- Corning Incorporated
- Danaher Corporation
- Lonza
- Bio-Rad Laboratories, Inc.
- PerkinElmer, Inc.
- PromoCell GmbH
- Bio-Techne Corporation

JHS

영문 목차

영문목차

Stem Cell Assays Market Summary

The global stem cell assays market size was estimated at USD 3.92 billion in 2024 and is projected to reach USD 12.85 billion by 2033, growing at a CAGR of 14.80% from 2025 to 2033. The growing need for physiologically relevant models in drug discovery, disease modeling, and regenerative medicine is the main factor propelling the market growth.

Pharmacies and researchers are looking for trustworthy platforms resembling human tissues more closely than conventional models, like organoid and iPSC-based systems. By improving drug efficacy and safety prediction, these assays lower late-stage failure rates and speed up the creation of novel treatments.

Global Stem Cell Assays Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global stem cell assays market report based on product, assay type, cell type, application, end-use, and region:

Product Outlook (Revenue, USD Million, 2021 - 2033)
Instruments
Kits & Reagents
Assay Type Outlook (Revenue, USD Million, 2021 - 2033)
Cell Viability Assay
Differentiation Assay
Proliferation Assay
Apoptosis Assay
Others
Cell Type Outlook (Revenue, USD Million, 2021 - 2033)
Adult stem cells
embryonic stem cells
induced pluripotent stem cells
Application Outlook (Revenue, USD Million, 2021 - 2033)
Regenerative Medicine & Therapy Development
Drug Discovery
Toxicity Testing
Clinical Research
Others
End-use Outlook (Revenue, USD Million, 2021 - 2033)
Academic and Research Institutions
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Market Definitions
- 1.2.1. Product Segment
- 1.2.2. Assay Type Segment
- 1.2.3. Cell Type Segment
- 1.2.4. Application Segment
- 1.2.5. End Use Segment
1.3. Information Analysis
- 1.3.1. Market formulation & data visualization
1.4. Data Validation & Publishing
1.5. Information Procurement
- 1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
- 1.10.1. Objective 1
- 1.10.2. Objective 2

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape

Chapter 3. Stem Cell Assays Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Increasing funding for stem cell research
  - 3.2.1.2. Growing demand for physiologically relevant models in drug discovery, regenerative medicine, and disease modeling
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Lack of stringent regulation
  - 3.2.2.2. High costs of advanced stem cell assays and associated instruments.
3.3. Stem Cell Assays Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis

Chapter 4. Stem Cell Assays Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Stem Cell Assays Market Product Movement Analysis
4.3. Global Stem Cell Assays Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Instruments
- 4.4.1. Instruments market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Kits & Reagents
- 4.5.1. Kits & Reagents market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Stem Cell Assays Market: Assay Type Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Stem Cell Assays Market Assay Type Movement Analysis
5.3. Global Stem Cell Assays Market Size & Trend Analysis, by Assay Type, 2021 to 2033 (USD Million)
5.4. Cell Viability Assay
- 5.4.1. Cell viability assay market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Differentiation Assay
- 5.5.1. Differentiation assay market estimates and forecasts 2021 to 2033 (USD Million)
5.6. Proliferation Assay
- 5.6.1. Proliferation assay market estimates and forecasts 2021 to 2033 (USD Million)
5.7. Apoptosis Assay
- 5.7.1. Apoptosis assay market estimates and forecasts 2021 to 2033 (USD Million)
5.8. Others
- 5.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Stem Cell Assays Market: Cell Type Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Global Stem Cell Assays Market Cell Type Movement Analysis
6.3. Global Stem Cell Assays Market Size & Trend Analysis, by Cell Type, 2021 to 2033 (USD Million)
6.4. Adult Stem Cells
- 6.4.1. Adult stem cells market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Embryonic Stem Cells
- 6.5.1. Embryonic stem cells market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Induced Pluripotent Stem Cells
- 6.6.1. Induced pluripotent stem cells market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Stem Cell Assays Market: Application Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Global Stem Cell Assays Market Application Movement Analysis
7.3. Global Stem Cell Assays Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
7.4. Regenerative Medicine & Therapy Development
- 7.4.1. Regenerative medicine & therapy development market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Drug discovery
- 7.5.1. Drug discovery market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Toxicity testing
- 7.6.1. Toxicity testing market estimates and forecasts 2021 to 2033 (USD Million)
7.7. Clinical Research
- 7.7.1. Clinical research market estimates and forecasts 2021 to 2033 (USD Million)
7.8. Others
- 7.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Stem Cell Assays Market: End Use Estimates & Trend Analysis

8.1. Segment Dashboard
8.2. Global Stem Cell Assays Market End Use Movement Analysis
8.3. Global Stem Cell Assays Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
8.4. Academic and Research Institutions
- 8.4.1. Academic and research institutions market estimates and forecasts 2021 to 2033 (USD Million)
8.5. Pharmaceutical and Biotechnology Companies
- 8.5.1. Pharmaceutical and biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
8.6. Contract Research Organizations
- 8.6.1. Contract research organizations market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Stem Cell Assays Market: Regional Estimates & Trend Analysis

9.1. Regional Market Share Analysis, 2024 & 2033
9.2. Regional Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
9.4. North America
- 9.4.1. U.S.
  - 9.4.1.1. Key country dynamics
  - 9.4.1.2. Competitive scenario
  - 9.4.1.3. Regulatory Framework
  - 9.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
- 9.4.2. Canada
  - 9.4.2.1. Key country dynamics
  - 9.4.2.2. Competitive scenario
  - 9.4.2.3. Regulatory Framework
  - 9.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
- 9.4.3. Mexico
  - 9.4.3.1. Key country dynamics
  - 9.4.3.2. Competitive scenario
  - 9.4.3.3. Regulatory Framework
  - 9.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
9.5. Europe
- 9.5.1. UK
  - 9.5.1.1. Key country dynamics
  - 9.5.1.2. Competitive scenario
  - 9.5.1.3. Regulatory Framework
  - 9.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
- 9.5.2. Germany
  - 9.5.2.1. Key country dynamics
  - 9.5.2.2. Competitive scenario
  - 9.5.2.3. Regulatory Framework
  - 9.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
- 9.5.3. France
  - 9.5.3.1. Key country dynamics
  - 9.5.3.2. Competitive scenario
  - 9.5.3.3. Regulatory Framework
  - 9.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
- 9.5.4. Italy
  - 9.5.4.1. Key country dynamics
  - 9.5.4.2. Competitive scenario
  - 9.5.4.3. Regulatory Framework
  - 9.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
- 9.5.5. Spain
  - 9.5.5.1. Key country dynamics
  - 9.5.5.2. Competitive scenario
  - 9.5.5.3. Regulatory Framework
  - 9.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
- 9.5.6. Norway
  - 9.5.6.1. Key country dynamics
  - 9.5.6.2. Competitive scenario
  - 9.5.6.3. Regulatory Framework
  - 9.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
- 9.5.7. Sweden
  - 9.5.7.1. Key country dynamics
  - 9.5.7.2. Competitive scenario
  - 9.5.7.3. Regulatory Framework
  - 9.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
- 9.5.8. Denmark
  - 9.5.8.1. Key country dynamics
  - 9.5.8.2. Competitive scenario
  - 9.5.8.3. Regulatory Framework
  - 9.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
9.6. Asia Pacific
- 9.6.1. Japan
  - 9.6.1.1. Key country dynamics
  - 9.6.1.2. Competitive scenario
  - 9.6.1.3. Regulatory Framework
  - 9.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
- 9.6.2. China
  - 9.6.2.1. Key country dynamics
  - 9.6.2.2. Competitive scenario
  - 9.6.2.3. Regulatory Framework
  - 9.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
- 9.6.3. India
  - 9.6.3.1. Key country dynamics
  - 9.6.3.2. Competitive scenario
  - 9.6.3.3. Regulatory Framework
  - 9.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
- 9.6.4. Australia
  - 9.6.4.1. Key country dynamics
  - 9.6.4.2. Competitive scenario
  - 9.6.4.3. Regulatory Framework
  - 9.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
- 9.6.5. South Korea
  - 9.6.5.1. Key country dynamics
  - 9.6.5.2. Competitive scenario
  - 9.6.5.3. Regulatory Framework
  - 9.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
- 9.6.6. Thailand
  - 9.6.6.1. Key country dynamics
  - 9.6.6.2. Competitive scenario
  - 9.6.6.3. Regulatory Framework
  - 9.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
9.7. Latin America
- 9.7.1. Brazil
  - 9.7.1.1. Key country dynamics
  - 9.7.1.2. Competitive scenario
  - 9.7.1.3. Regulatory Framework
  - 9.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
- 9.7.2. Argentina
  - 9.7.2.1. Key country dynamics
  - 9.7.2.2. Competitive scenario
  - 9.7.2.3. Regulatory Framework
  - 9.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
9.8. MEA
- 9.8.1. South Africa
  - 9.8.1.1. Key country dynamics
  - 9.8.1.2. Competitive scenario
  - 9.8.1.3. Regulatory Framework
  - 9.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
- 9.8.2. Saudi Arabia
  - 9.8.2.1. Key country dynamics
  - 9.8.2.2. Competitive scenario
  - 9.8.2.3. Regulatory Framework
  - 9.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
- 9.8.3. UAE
  - 9.8.3.1. Key country dynamics
  - 9.8.3.2. Competitive scenario
  - 9.8.3.3. Regulatory Framework
  - 9.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
- 9.8.4. Kuwait
  - 9.8.4.1. Key country dynamics
  - 9.8.4.2. Competitive scenario
  - 9.8.4.3. Regulatory Framework
  - 9.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 10. Competitive Landscape

10.1. Company/Competition Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2024
10.4. Company Profiles/Listing
- 10.4.1. Thermo Fisher Scientific Inc.
  - 10.4.1.1. Company overview
  - 10.4.1.2. Financial performance
  - 10.4.1.3. Product/Service benchmarking
  - 10.4.1.4. Strategic initiatives
- 10.4.2. Merck KGaA
  - 10.4.2.1. Company overview
  - 10.4.2.2. Financial performance
  - 10.4.2.3. Product/Service benchmarking
  - 10.4.2.4. Strategic initiatives
- 10.4.3. STEMCELL Technologies Inc.
  - 10.4.3.1. Company overview
  - 10.4.3.2. Financial performance
  - 10.4.3.3. Product/Service benchmarking
  - 10.4.3.4. Strategic initiatives
- 10.4.4. Corning Incorporated
  - 10.4.4.1. Company overview
  - 10.4.4.2. Financial performance
  - 10.4.4.3. Product/Service benchmarking
  - 10.4.4.4. Strategic initiatives
- 10.4.5. Danaher Corporation
  - 10.4.5.1. Company overview
  - 10.4.5.2. Financial performance
  - 10.4.5.3. Product/Service benchmarking
  - 10.4.5.4. Strategic initiatives
- 10.4.6. Lonza
  - 10.4.6.1. Company overview
  - 10.4.6.2. Financial performance
  - 10.4.6.3. Product/Service benchmarking
  - 10.4.6.4. Strategic initiatives
- 10.4.7. Bio-Rad Laboratories, Inc.
  - 10.4.7.1. Company overview
  - 10.4.7.2. Financial performance
  - 10.4.7.3. Product/Service benchmarking
  - 10.4.7.4. Strategic initiatives
- 10.4.8. PerkinElmer, Inc.
  - 10.4.8.1. Company overview
  - 10.4.8.2. Financial performance
  - 10.4.8.3. Product/Service benchmarking
  - 10.4.8.4. Strategic initiatives
- 10.4.9. PromoCell GmbH
  - 10.4.9.1. Company overview
  - 10.4.9.2. Financial performance
  - 10.4.9.3. Product/Service benchmarking
  - 10.4.9.4. Strategic initiatives
- 10.4.10. Bio-Techne Corporation
  - 10.4.10.1. Company overview
  - 10.4.10.2. Financial performance
  - 10.4.10.3. Product/Service benchmarking
  - 10.4.10.4. Strategic initiatives

한글목차

줄기세포 어세이 시장 요약

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 줄기세포 어세이 시장의 변수, 동향, 범위

제4장 줄기세포 어세이 시장 : 제품별 추정 및 동향 분석

제5장 줄기세포 어세이 시장 : 어세이 유형별 추정 및 동향 분석

제6장 줄기세포 어세이 시장 : 세포 유형별 추정 및 동향 분석

제7장 줄기세포 어세이 시장 : 용도별 추정 및 동향 분석

제8장 줄기세포 어세이 시장 : 최종 용도별 추정 및 동향 분석

제9장 줄기세포 어세이 시장 : 지역별 추정 및 동향 분석